Cvs Health (CVS) Short-term Investments (2009 - 2026)

Cvs Health's Short-term Investments history runs 18 years deep, the most recent figure standing at $2.3 billion for Q1 2026.

• Quarterly Short-term Investments fell 12.34% year-over-year to $2.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 billion (down 12.34% YoY) and the FY2025 annual result came in at $2.1 billion, down 10.88% from the prior year.
• Short-term Investments was $2.3 billion for Q1 2026 at Cvs Health, up from $2.1 billion in the prior quarter.
• Across five years, Short-term Investments topped out at $3.8 billion in Q2 2024 and bottomed at $2.1 billion in Q3 2025.
• A 5-year average of $2.8 billion and a median of $2.8 billion in 2024 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2024 — Short-term Investments rose 21.92% — and 2025, when it slumped 36.46%.
• Cvs Health's Short-term Investments stood at $2.8 billion in 2022, then gained by 17.31% to $3.3 billion in 2023, then declined by 26.14% to $2.4 billion in 2024, then slipped by 10.88% to $2.1 billion in 2025, then climbed by 5.36% to $2.3 billion in 2026.
• Business Quant data shows CVS's Short-term Investments at $2.3 billion in Q1 2026, $2.1 billion in Q4 2025, and $2.1 billion in Q3 2025.